|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Medicine (Ms. Appleton, and Drs. Adams and Ruffin) and Surgery (Mr. Peacock), University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville, SA, Australia; private practice (Dr. Porter), Adelaide, SA, Australia.
Correspondence to: Robert Adams, MBBS, MD, Department of Medicine, The Queen Elizabeth Hospital, 28 Woodville Rd, Woodville, SA, Australia 5011; e-mail: robert.adams{at}nwahs.sa.gov.au
Objectives: To determine long-term survival rates of patients who underwent lung volume reduction surgery (LVRS) for emphysema and the factors associated with longer survival, and to evaluate levels of perceived dyspnea and health-related quality of life (HRQL) after a follow-up period of 3 to 5.5 years.
Design: Retrospective observational study.
Setting: Academic medical center
Methods: Telephone and postal surveys were used to obtain patient dyspnea scores and HRQL scores. Hospital databases and state registries were searched to determine patient survival and pulmonary function.
Results: Of 54 patients undergoing LVRS, 29 patients (18 men and 11 women) were available for follow-up, which ranged from 36 to 66 months (mean ± SE, 51 ± 1.5 months). There was significant sustained improvement in modified Medical Research Council scores compared to pre-LVRS: 2.19 ± 0.19 vs 2.88 ± 0.14 (p = 0.0000). Eleven of 22 patients demonstrated an increase in all three Mahler baseline dyspnea index grades of at least one level. Baseline body mass index (BMI) and post-LVRS length of stay (LOS) were significantly associated with survival: survivor vs deceased baseline BMI, 24.2 ± 0.6 vs 21.4 ± 0.5 (p = 0.002), and post-LVRS LOS, 15.4 ± 1.7 days vs 28.7 ± 5.3 days (p = 0.015). Compared to pre-LVRS, 20 patients with mean follow-up time of 45 months demonstrated significant sustained improvements in FEV1 percentage of predicted (31.4 ± 2.1% vs 39.8 ± 3.5%, p = 0.038), total lung capacity percentage of predicted (136 ± 4% vs 122 ± 3%, p = 0.0004), and residual volume percentage of predicted (237 ± 14% vs 172 ± 11%, p = 0.0001). Patient HRQL measured using the Dartmouth Primary Care Co-operative Quality of Life questionnaire was more favorable than that reported in aged-care settings. Caregiver burden scale scores indicate caring for a recipient of LVRS carries similar burden to that for caring for individuals with other chronic illnesses.
Conclusions: In this population, a majority of the LVRS patients survived for ≥ 3 years. Among survivors, dyspnea and lung function benefits were seen. Baseline BMI and postoperative LOS were significantly associated with survival.
Key Words: emphysema lung diseases, obstructive lung volume reduction surgery
This article has been cited by other articles:
![]() |
Q.-Y. Tan, R.-W. Wang, Y.-G. Jiang, S.-Z. Fan, M. K.Y. Hsin, T.-Q. Gong, J.-H. Zhou, and Y.-P. Zhao Lung Volume Reduction Surgery Allows Esophageal Tumor Resection in Selected Esophageal Carcinoma With Severe Emphysema Ann. Thorac. Surg., November 1, 2006; 82(5): 1849 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Gorman, D. K. McKenzie, J. E. Butler, J. F. Tolman, and S. C. Gandevia Diaphragm Length and Neural Drive after Lung Volume Reduction Surgery Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1259 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Yusen and B. Littenberg Integrating Survival and Quality of Life Data in Clinical Trials of Lung Disease: The Case of Lung Volume Reduction Surgery Chest, April 1, 2005; 127(4): 1094 - 1096. [Full Text] [PDF] |
||||
![]() |
F. Laghi, A. Jubran, A. Topeli, P. J. Fahey, E. R. Garrity Jr, D. J. de Pinto, and M. J. Tobin Effect of Lung Volume Reduction Surgery on Diaphragmatic Neuromechanical Coupling At 2 Years Chest, June 1, 2004; 125(6): 2188 - 2195. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |